Doxazosin Tablet
Product Images NDC 84677-047

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 84677-047). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

84677-044-01ol- Doxazosin Tablet 1mg 100ct.jpg (84677 044 01ol Doxazosin Tablet 1mg 100ct)

This is a description of Ach Tablets, USP, which contain doxazosin mesylate equivalent to 1 mg of doxazosin. The usual dosage information can be found in the package insert. The tablets are to be stored in a tight, light-resistant container with a child-resistant closure at 20°C to 25°C (68°F to 77°F). The medication should be kept out of reach of children. Manufactured by GSMS, Incorporated based in Camarillo, California.*

FDA Label Image

84677-045-01ol- Doxazosin Tablet 2mg 100ct.jpg (84677 045 01ol Doxazosin Tablet 2mg 100ct)

FDA Label Image

84677-046-01ol- Doxazosin Tablet 4mg 100ct.jpg (84677 046 01ol Doxazosin Tablet 4mg 100ct)

This is information about Doxazosin Tablets, USP that contains doxazosin mesylate, USP equivalent to 4 mg doxazosin as a free base per tablet. The usual dosage information is included in the package insert. It is recommended to store the tablets in a tight container with a child-resistant closure at temperatures between 20°C to 25°C (68°F to 77°F). The medication should be kept out of reach of children. This product is distributed by GSMS, Incorporated, located in Camarillo, CA, USA.*

FDA Label Image

84677-047-01ol- Doxazosin Tablet 8mg 100ct.jpg (84677 047 01ol Doxazosin Tablet 8mg 100ct)

This is a description of Doxazosin tablets, a medication used to treat high blood pressure and enlarged prostate. Each tablet contains doxazosin mesylate equivalent to 8 mg of doxazosin. It is important to follow the prescribing information provided and store the medication in a child-resistant container at the recommended temperature. The text also includes instructions for the pharmacist to provide patient information and mentions that Doxazosin is available in a pack of 100 tablets.*

FDA Label Image

Structure (C2bacf15 E521 4d06 B4c6 45b40036b73c 01)

FDA Label Image

Image (C2bacf15 E521 4d06 B4c6 45b40036b73c 02)

This text appears to be a statistical analysis of maximum flow rates in relation to various doses of doxazosin in studies involving patients with BPH (benign prostatic hyperplasia). The data includes baseline measurements, changes in flow rates, and comparisons between different dosages of doxazosin and placebos. Study durations, dosing regimens, symptom scores, and questionnaire results are also described. The findings suggest that doxazosin at certain doses had notable effects on flow rates compared to placebos, with statistically significant differences highlighted.*

FDA Label Image

Image (C2bacf15 E521 4d06 B4c6 45b40036b73c 03)

The text describes a study comparing the mean change in total symptom score and mean increase in maximum urinary flow rate (mUsec) from baseline over a period of treatment weeks with Doxazosin. The results are compared to a placebo, and notable significance levels are indicated in relation to placebo and baseline (p<0.05). Doxazosin titration to a maximum of 8 mg was likely part of the treatment protocol.*

FDA Label Image

Logo (C2bacf15 E521 4d06 B4c6 45b40036b73c 04)

FDA Label Image

Logo (C2bacf15 E521 4d06 B4c6 45b40036b73c 05)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.